Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Follitropin Delta vs Follitropin Alfa for Ovarian Stimulation (ADAPT-1)
NCT05263388Phase 3Completed
- Sponsor
- Ferring Pharmaceuticals
- Start
- Jul 2022
- Primary completion
- Apr 2024
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 5
01
Overview
A Phase 3 trial of follitropin delta in infertility, sponsored by Ferring Pharmaceuticals. Started Jul 2022; status: completed.
02
Drugs
follitropin delta
03
Conditions
infertility
Beyond the preview
Go deeper on NCT05263388.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05263388.